Cargando…
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells
BACKGROUND: Multiple genetic modifications may be required to develop potent off-the-shelf chimeric antigen receptor (CAR) T cell therapies. Conventional CRISPR-Cas nucleases install sequence-specific DNA double-strand breaks (DSBs), enabling gene knock-out or targeted transgene knock-in. However, s...
Autores principales: | Glaser, Viktor, Flugel, Christian, Kath, Jonas, Du, Weijie, Drosdek, Vanessa, Franke, Clemens, Stein, Maik, Pruß, Axel, Schmueck-Henneresse, Michael, Volk, Hans-Dieter, Reinke, Petra, Wagner, Dimitrios L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123993/ https://www.ncbi.nlm.nih.gov/pubmed/37095570 http://dx.doi.org/10.1186/s13059-023-02928-7 |
Ejemplares similares
-
CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023) -
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021) -
Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells
por: Kath, Jonas, et al.
Publicado: (2022) -
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
por: Wendering, Desiree J., et al.
Publicado: (2019) -
Selecting for CRISPR-Edited Knock-In Cells
por: Reuven, Nina, et al.
Publicado: (2022)